MEGHAN STUFFLEBEEM: Open Payments
NPI 1336742477 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,626 in 76 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,626
Food & beverage: $1,526Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $351 |
| Janssen Biotech, Inc. | 9 | $261 |
| LEO Pharma Inc. | 9 | $250 |
| UCB, Inc. | 9 | $180 |
| Lilly USA, LLC | 4 | $151 |
| GENZYME CORPORATION | 5 | $105 |
| Novartis Pharmaceuticals Corporation | 4 | $102 |
| Amgen Inc. | 4 | $85 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $82 |
| Incyte Corporation | 2 | $58 |
Products named: RINVOQ, TREMFYA, ADBRY, Bimzelx, EBGLYSS, DUPIXENT, SKYRIZI, OTEZLA.
Industry payments across VA — which companies pay providers there.
